Lithium as a pharmacological approach to treat behavioral complications in Alzheimer’s disease: a preclinical study

Monique Patricio Singulani, Rosana Camarini, Leda Leme Talib, Luiz Roberto Britto, Orestes Vicente Forlenza · 2025

Read Lithium as a pharmacological approach to treat behavioral complications in Alzheimer’s disease: a preclinical study by Monique Patricio Singulani, Rosana Camarini, Leda Leme Talib, Luiz Roberto Britto, Orestes Vicente Forlenza (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11710544.txt.

Description

Monique Singulani and co-authors test lithium, the classic mood drug, against behavior problems in Alzheimer's mice. Nearly all patients develop anxiety or apathy, yet few treatments help. Mice bred for the disease ate lithium laced chow for twelve weeks in mid life. A battery of mazes and swim and taste tests followed.

Treated mice showed far less anxiety like and despair like behavior than untreated peers. Their taste for sweet water, a pleasure gauge, recovered. Short term recognition memory also held up better. Brain staining tracked the amyloid side of the story. The authors make a preclinical case for lithium trials aimed at behavior, not just memory.

Catalog record

CREATORMonique Patricio Singulani, Rosana Camarini, Leda Leme Talib, Luiz Roberto Britto, Orestes Vicente Forlenza
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE3 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11710544

Browse the full library · About the Tower of Babel